HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

917.461

-7.804-0.84%

Number of Gainers:5

Number of Losers:12

Number of Flat:- -

PE:- -

High:925.384

Open:925.265

Low:914.357

Close:925.265

Volume:125.54M

Turnover:1.23B

Market Cap:617.11B

Float Cap:514.01B

Loading ...

Guangzhou Baiyunshan Pharmaceutical - Disposal of First New Underlying Assets of Gp Corp. to Industrial Securities Asset Management for Rmb146.3 Mln

THOMSON REUTERS

Sino Biopharm Wins NMPA Nod to Start LM-364 Nectin-4 TME ADC Trial in Solid Tumors

Sino Biopharmaceutical - Lm-364 'Nectin-4Tme ADC' Receives Nmpa Clinical Trial Approval for Advanced Solid Tumors

THOMSON REUTERS

CSPC Pharmaceutical Group Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

BYD Electronic (International) Stock Rises 6.3% in Hong Kong

AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium

Baiyunshan's First-Half Profit Plunges 16.7%: Herbal Tea Business Under Pressure, Lingering Legal Battle Over Jinge Resurfaces

Shanghai Fosun Pharmaceutical's GR1803 Injection Gets Conditional Approval in China

MT Newswires Live

Fosun Chairman Guo Guangchang: Staying the Course on Core Sectors Like Pharma with R&D Spend of RMB 4.2 Billion in H1, Up 16.7%

Hong Kong Market Pulse | BYD Electronic Climbs Over 6% to Lead Blue Chips, Interim Results Due Today

Shares of TYK Medicines-B Jump Nearly 15% in Morning Trading as Its Innovative Drug TY-9591 Receives Conditional Market Approval

Dizal Pharma Resubmits H-Share Listing Application to Hong Kong Stock Exchange

Sihuan Pharmaceutical (SEHK:460) Stock Price Lags Profit Recovery as Valuation Stretches

Simply Wall St.

TYK MEDICINES-B Secures Conditional NMPA Approval for Its Novel EGFR-TKI Therapy

Great-Sun Foods Posts 250% Surge in Total Profit as Pharmaceutical Arm Begins Consolidation

Fosun Pharma Secures Conditional NMPA Approval for GR1803 Injection

Shanghai Fosun Pharma - Recently, Marketing Registration Application for Gr1803 Injection Has Been Approved with Conditions by Nmpa China

THOMSON REUTERS

CSPC Pharma Gets Trial Nod for Weight Management Drug in China

MT Newswires Live

Healthcare Sector Set for Selective Gains in Second Half, Says Great Wall Fund Manager

Sihuan Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 0.81

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK1515/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":917.4613,"timestamp":1788239160407,"preClose":925.2649,"halted":0,"volume":125543054,"delay":0,"changeRate":-0.008434,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-7.803589,"latestTime":"09-01 13:06:03","open":925.2649,"high":925.38446,"low":914.35736,"amount":1231025035,"amplitude":0.011918,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788250200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"pbRate":1.389189,"peRate":17.860083,"turnoverRate":0.00172,"increases":5,"decrements":12,"flats":0,"marketCap":617106041088,"floatMarketCap":514009696000},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":925.38446,"amplitude":0.011918,"preClose":925.2649,"low":914.35736,"pbRate":"1.389189","latestPrice":917.4613,"volume":125543054,"delay":0,"open":925.2649,"prevYearClose":1190.107,"prevWeekClose":933.888,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":935.94,"twentyDayClose":925.982,"sixtyDayClose":907.099,"secType":"PLATE","market":"HK","turnoverRate":0.00172,"peRate":17.860083,"marketCap":617106041088,"floatMarketCap":514009696000,"timestamp":1788239160407,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":5,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662406854","title":"Guangzhou Baiyunshan Pharmaceutical - Disposal of First New Underlying Assets of Gp Corp. to Industrial Securities Asset Management for Rmb146.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662406854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662406854?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:48","pubTimestamp":1787906907,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44O1M2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0175","BK1521","BK1606","600332","BK0196","BK1515","BK0239","00874","BK0096","BK0183","BK1197","BK0012","BK0188","BK1191","BK0097","BK0028","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662467050","title":"Sino Biopharm Wins NMPA Nod to Start LM-364 Nectin-4 TME ADC Trial in Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662467050","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662467050?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:35","pubTimestamp":1787906126,"startTime":"0","endTime":"0","summary":"Sino Biopharm wins NMPA nod to start LM-364 Nectin-4 TME ADC trial in solid tumorsSino Biopharmaceutical’s unit LaNova Medicines secured NMPA clearance to start China trials of LM-364, a Nectin-4 TME-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL9Rbl7n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","BK1521","BK1589","IE00BZ08YR35.GBP","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050926","title":"Sino Biopharmaceutical - Lm-364 'Nectin-4Tme ADC' Receives Nmpa Clinical Trial Approval for Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662050926?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:32","pubTimestamp":1787905928,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44O1R1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ08YT58.USD","BK1191","01177","BK1589","IE00BZ08YR35.GBP","BK1515","IE00BZ08YS42.EUR","BK1521","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050237","title":"CSPC Pharmaceutical Group Stock Sheds 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662050237?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:32","pubTimestamp":1787905920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. shed 1.5% to 9.53 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25584.79.The stock's fall snapped a four-day winning streak.CSPC Pharmaceutical Group Ltd. closed 18% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.7%, SSY Group Ltd. rose 0.4%, and United Laboratories International Holdings Ltd. fell 1.8%.Trading volume totaled 74.5 million shares, compared to the 50-day average of 104.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","IE0008368742.USD","IE00B543WZ88.USD","LU0140636845.USD","LU1328277881.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU0501845795.SGD","IE00BZ08YT58.USD","LU1813983027.USD","SG9999004220.SGD","LU1951186391.HKD","LU0314109678.HKD","LU0880133367.SGD","LU2039709279.SGD","BK1515","LU1226288170.HKD","BK1191","LU1226288253.USD","01093","IE00B5MMRT66.SGD","LU1152091168.USD","LU1993786604.SGD","LU1226287875.USD","LU1807302812.USD","LU1226287792.SGD","HK0000165453.HKD","IE00B031HY20.USD","LU0315179316.USD","LU0072913022.USD","IE00BZ08YR35.GBP","LU1152091754.HKD","BK1521","LU1226287529.USD","LU0067412154.USD","IE0008369823.USD","LU1008478684.HKD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662943050","title":"BYD Electronic (International) Stock Rises 6.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2662943050","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662943050?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:30","pubTimestamp":1787905800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. rose 6.3% to 24.76 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25584.79.This was the stock's third consecutive day of gains.BYD Electronic  Co. Ltd. closed 47% short of its 52-week high of HK$46.70, which the company achieved Sept. 2.The stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. fell 8.4%.Trading volume totaled 22.1 million shares, compared to the 50-day average of 11.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1167","00285","BK1504","BK1607","BK1540","BK1515","BK1582","LU0274383008.USD","LU0348766576.USD","LU0348767384.USD","BK1149","BK1589","BK1580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137057087","title":"AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium","url":"https://stock-news.laohu8.com/highlight/detail?id=1137057087","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137057087?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:21","pubTimestamp":1787905307,"startTime":"0","endTime":"0","summary":"As of the close of trading on August 28, the latest A-H share premium data has been released, offering a comprehensive snapshot of the valuation gap between dual-listed stocks. The rankings highlight...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1190","BK1530","LU2394011477.USD","LU0821914370.USD","LU0516422440.USD","BK1193","LU0320764755.SGD","LU1244550494.USD","BK1144","BK1205","BK1514","LU0348825331.USD","IE00B5MMRT66.SGD","IE00BF5LJ272.USD","LU1675838814.USD","LU0082770016.SGD","LU1813983027.USD","LU2476274720.SGD","LU1251922891.USD","BK1505","LU1188198961.HKD","03308","LU0588546209.SGD","LU2177674079.SGD","BK1554","LU0672654166.SGD","LU0648948544.HKD","LU0165289439.USD","LU0791591158.USD","BK1231","LU0456827905.SGD","LU1688375341.USD","BK1546","HK0000352291.HKD","BK1507","LU0039217434.USD","LU0082770016.USD","BK1116","LU0329678337.USD","LU1655091616.SGD","HK0000352382.USD","LU0048580855.USD","LU0449509016.USD","LU0287142896.SGD","LU0307460666.USD","LU1328277881.USD","LU2476274308.USD","LU0327786744.USD","LU0862451753.SGD","06821","LU0708995583.HKD","LU1244550577.SGD","LU0244354667.USD","BK1198","02727","03908","LU1115378108.SGD","LU0231483743.USD","IE00BZ08YT58.USD","LU0329678170.USD","LU0516423091.SGD","LU1105468828.SGD","LU0054450605.USD","BK1594","LU0516423174.USD","HK0000252152.HKD","03750","LU0828237510.HKD","LU0029875118.USD","02359","LU0348766576.USD","LU0449515922.USD","BK1209","SG9999002463.SGD","LU1719994722.HKD","BK1583","IE00B3M56506.USD","HK0001040168.HKD","LU1282649810.SGD","SG9999001093.SGD","LU0106959298.USD","LU0043850808.USD","LU0890818403.SGD","LU0589944569.HKD","LU0516422366.SGD","LU1366334578.USD","IE0008368742.USD","LU0228367735.SGD","HK0000306685.HKD","LU0918141887.USD","BK1523","BK1506","LU0463099449.HKD","LU0049853897.USD","LU0181495838.USD","IE00B29SXG58.USD","BK1610","02338","BK1544","LU0149721374.USD","BK1562","LU0228659784.USD","LU0096374516.USD","LU0620787316.HKD","LU0266512127.USD","LU3063872942.SGD","LU0823426480.USD","BK1533","LU1961090484.USD","LU2045819591.USD","BK1105","LU0315179316.USD","IE00BVYPNQ40.USD","HK0000252160.HKD","SG9999006597.SGD","LU1224709979.USD","LU1152091754.HKD","LU0269904917.USD","03328","LU0531970944.HKD","BK1551","LU0456846285.SGD","LU0501845795.SGD","LU0320764599.SGD","BK1592","LU0828238088.HKD","LU1046422090.SGD","LU0531971595.HKD","LU0345780521.USD","LU1808992512.USD","LU0572944931.SGD","LU2097828631.EUR","LU0348805143.USD","BK1161","LU1282649141.HKD","LU1008478684.HKD","LU1152091168.USD","LU1988902786.USD","LU0370786039.SGD","03296","159982","00300","LU2242644610.SGD","BK1515","LU0359201885.HKD","LU0348814723.USD","LU0229945570.USD","LU1064131342.USD","BK1574","BK1564","BK1122","00991","BK1576","00981","LU2097828805.USD","BK1249","LU0540923850.HKD","00187","LU0886674414.USD","IE00BMCWC346.EUR","BK1141","LU0328353924.USD","LU0456854461.SGD","LU1831875114.USD","LU0051755006.USD","LU0640798160.USD","LU0214875030.USD","BK1501","IE00BYV24P56.USD","LU0254981946.USD","03200","LU0791590937.USD","LU2008162690.USD","LU0737861699.HKD","IE00B0169L03.USD","LU1481107354.HKD","LU0828237940.HKD","LU0543330566.HKD","LU0314109678.HKD","EWH","LU1769817096.USD","IE00B543WZ88.USD","BK1202","BK1522","LU0211977185.USD","IE0031814852.USD","LU0117841782.USD","00317","LU0163747925.USD","BK1614","LU0871576103.HKD","HK0000320264.USD","LU2097828474.EUR","02475","BK1149","00916","LU0868486357.SGD","LU1880383366.USD","LU2264538146.SGD","LU1242518857.USD","LU1720050803.USD","BK1526","LU0106252389.USD","82846","LU1023057109.AUD","IE0034224299.USD","LU1769817179.HKD","LU2125910500.SGD","IE00BGHQDM52.EUR","BK1191","02846","BK1183","03986","SG9999014674.SGD","LU2778985437.USD","HK0000500386.USD","LU0348827113.USD","LU0431992006.USD","01812","BK1558","BK1223","03678","HK0000306701.USD","LU2097828557.USD","LU1282649067.USD","83188","LU0067412154.USD","LU0797268264.HKD","LU0345780281.USD","LU0061477393.USD","IE0008369823.USD","06869","LU0266512473.USD","BK1516","HK0001040143.USD","01349","LU1303224171.USD","00638","LU0348767384.USD","83130","BK1560","02827","03130","LU2226246903.HKD","LU0072913022.USD","BK1147","LU2097828714.EUR","03143","LU0164939612.USD","LU0210526637.USD","01057","06185","LU1282648689.USD","LU0164880469.USD","BK1154","LU0052750758.USD","LU0348816934.USD","BK1125","SG9999004220.SGD","LU1226287529.USD","00568","LU0607220059.USD","399300","LU2399975544.HKD","LU1504937902.USD","LU1794554557.SGD","LU0516422952.EUR","LU0164865239.USD","IE00BZ08YR35.GBP","LU0543330483.HKD","LU0128522157.USD","03968","LU0348735423.USD","LU0979878070.USD","01033","LU0488056044.USD","LU1255011170.USD","LU0823040885.USD","02691","LU0326950275.SGD","SG9999002828.SGD","LU0348788117.USD","LU0509642566.USD","IE00B031J352.USD","LU1048596156.SGD","LU1993786604.SGD","01108","LU0359202008.SGD","02068","LU0417516902.SGD","LU0140636845.USD","BK1170","IE00BVYPNP33.GBP","LU0455707207.USD","LU0634319403.HKD","BK1214","BK1607","IE00BZ08YS42.EUR","01989","LU1244550221.USD","07233","LU1211504680.USD","LU0918141705.HKD","LU1770034418.SGD","LU0173614495.USD","LU0593848301.USD","IE00B031HY20.USD","03188","LU0384037296.USD","LU0149534421.HKD","LU0823426308.USD","IE0032431581.USD","LU0417516738.SGD","00553","00042","HK0000320223.HKD","LU1960683339.HKD","LU0561508036.HKD","LU0359201612.USD","LU1366334651.USD","BK1171","LU0469268626.HKD","SG9999011746.SGD","LU0502904849.HKD","BK1521","LU2294711473.HKD","LU2039709279.SGD","LU0880133367.SGD","LU1880383440.USD","BK1163","02899","LU0737861772.HKD","BK1148","LU1242518931.SGD","LU1807302812.USD","SG9999001226.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139991411","title":"Baiyunshan's First-Half Profit Plunges 16.7%: Herbal Tea Business Under Pressure, Lingering Legal Battle Over Jinge Resurfaces","url":"https://stock-news.laohu8.com/highlight/detail?id=1139991411","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139991411?lang=en_us&edition=fundamental","pubTime":"2026-08-28 14:31","pubTimestamp":1787898681,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA: 600332) has released its interim report for the first half of 2026, revealing a complex financial picture. The company recorded...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874","BK1606","BK0012","600332","BK0239","BK1521","BK0028","BK0070","BK0097","BK0183","BK0196","BK1191","BK1515","BK1197","BK0188","BK0175","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662056779","title":"Shanghai Fosun Pharmaceutical's GR1803 Injection Gets Conditional Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662056779","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662056779?lang=en_us&edition=fundamental","pubTime":"2026-08-28 13:20","pubTimestamp":1787894451,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical's  GR1803 injection received conditional approval from China's National Medical Products Administration as a multiple myeloma treatment, according to a Friday disclosure on the Shanghai bourse.The drug, which has the generic name veritumab injection, is for adult patients with relapsed or refractory multiple myeloma who have previously received at least three lines of therapy, including a proteasome inhibitor and an anti-CD38 monoclonal antibody.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0096","BK1593","BK0187","BK0012","600196","BK0060","BK0188","02196","BK0175","BK1515","BK0028","BK0239","BK0183","BK0196","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150078686","title":"Fosun Chairman Guo Guangchang: Staying the Course on Core Sectors Like Pharma with R&D Spend of RMB 4.2 Billion in H1, Up 16.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150078686","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150078686?lang=en_us&edition=fundamental","pubTime":"2026-08-28 13:11","pubTimestamp":1787893863,"startTime":"0","endTime":"0","summary":"During the 2026 interim results conference held in Hong Kong on August 28, FOSUN INTL Chairman Guo Guangchang stated that the company's first-half performance was impressive, confirming that the \"fix...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","BK1574","159938","00656","BK1515","BK1230","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197487126","title":"Hong Kong Market Pulse | BYD Electronic Climbs Over 6% to Lead Blue Chips, Interim Results Due Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1197487126","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197487126?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:08","pubTimestamp":1787890092,"startTime":"0","endTime":"0","summary":"BYD Electronic (00285) surged more than 6% in Hong Kong trading, currently leading blue-chip stocks. As of the time of writing, the stock was up 6.61% at HK$24.84, with trading turnover reaching...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1504","BK1582","BK1167","BK1149","BK1515","BK1580","KCAI","LU0274383008.USD","LU0348766576.USD","LU0348767384.USD","BK1607","BK4585","00285","VXUS","BK1540","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156832241","title":"Shares of TYK Medicines-B Jump Nearly 15% in Morning Trading as Its Innovative Drug TY-9591 Receives Conditional Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1156832241","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156832241?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:41","pubTimestamp":1787881292,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) saw its shares surge nearly 15% in early trading, with the stock climbing 14.99% to HK$7.825 at the time of writing, on a turnover of HK$2.758 million.On the evening of August...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","IBBQ","06978","MEDX","02410","BK1161","09939","LNGR","159992","IPOS","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148206442","title":"Dizal Pharma Resubmits H-Share Listing Application to Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=1148206442","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148206442?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:28","pubTimestamp":1787876894,"startTime":"0","endTime":"0","summary":"Dizal Pharmaceutical Co., Ltd. (688192.SH) has announced it resubmitted its application to list H-shares on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX) on August 27, 2026, with...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IPOS","159938","BK0239","BK1515","BK1161","09939","688192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084715","title":"Sihuan Pharmaceutical (SEHK:460) Stock Price Lags Profit Recovery as Valuation Stretches","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084715","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084715?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:24","pubTimestamp":1787840647,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group entered these results following a period of weak share price performance, with the stock down over the past week, month and quarter, yet trading on a rich P/E of 21x. That is a set up for emotional trading. The headline from this half year is simple. Profitability has firmed up, with basic earnings per share at C¥0.0249 on revenue of C¥1,161.2m. The tug of war now is between investors who are concerned about the valuation strain and those who see a company...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/sihuan-pharmaceutical-sehk460-stock-price-lags-profit-recove","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/sihuan-pharmaceutical-sehk460-stock-price-lags-profit-recove","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00460","BK1600","BK1191","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191561333","title":"TYK MEDICINES-B Secures Conditional NMPA Approval for Its Novel EGFR-TKI Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1191561333","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191561333?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:26","pubTimestamp":1787837163,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has announced that its independently developed next-generation EGFR-TKI innovative drug, Duxenaitinib Mesylate Tablets (TY-9591), has received conditional marketing approval...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","09939","BK1161","IPOS","BK1515","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167119384","title":"Great-Sun Foods Posts 250% Surge in Total Profit as Pharmaceutical Arm Begins Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=1167119384","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167119384?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:22","pubTimestamp":1787833347,"startTime":"0","endTime":"0","summary":"Great-Sun Foods Co.,Ltd. (603336.SH) released its 2026 semi-annual report on the evening of August 27. Despite short-term pressure in its core fruit and vegetable business due to industry cycles, the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159938","BK0238","BK1161","603336","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199001247","title":"Fosun Pharma Secures Conditional NMPA Approval for GR1803 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1199001247","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199001247?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:20","pubTimestamp":1787829620,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (H-share ticker: 02196) announced that its controlling subsidiary, Chongqing Yaoyou Pharmaceutical Co., Ltd. (\"Yaoyou Pharma\"), has obtained...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK1515","BK1191","02196","BK0183","BK0175","BK0096","BK0196","BK0239","BK1593","BK0187","BK0012","600196","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709438","title":"Shanghai Fosun Pharma - Recently, Marketing Registration Application for Gr1803 Injection Has Been Approved with Conditions by Nmpa China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662709438?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:06","pubTimestamp":1787828777,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","600196","BK0196","BK0188","BK0012","BK1593","BK0028","BK1515","BK0239","BK0175","BK0187","02196","BK0183","BK0096","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662457709","title":"CSPC Pharma Gets Trial Nod for Weight Management Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662457709","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662457709?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:05","pubTimestamp":1787828740,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  obtained clinical trial approval for the SYH2092 injection from China's National Medical Products Administration, according to a Thursday Hong Kong bourse filing.The product has the potential to bring significant clinical benefits for weight management in patients with obesity and improve glycaemic control in patients with type 2 diabetes mellitus.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0008369823.USD","LU1152091754.HKD","LU1226287875.USD","IE00B031HY20.USD","KURE","LU1008478684.HKD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1951186391.HKD","SG9999004220.SGD","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","LU1813983027.USD","LU1993786604.SGD","LU0315179316.USD","HK0000165453.HKD","BK1191","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU1807302812.USD","IE00BZ08YT58.USD","BK1515","LU1226288253.USD","LU0314109678.HKD","LU1226288170.HKD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00B5MMRT66.SGD","01093","LU0067412154.USD","IE0008368742.USD","IE00B543WZ88.USD","BK1521","LU0140636845.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101395901","title":"Healthcare Sector Set for Selective Gains in Second Half, Says Great Wall Fund Manager","url":"https://stock-news.laohu8.com/highlight/detail?id=1101395901","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101395901?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:41","pubTimestamp":1787827277,"startTime":"0","endTime":"0","summary":"After a period of correction and consolidation, the healthcare sector has shown robust performance over the past two months, with the once-prominent \"golden track\" seemingly returning to mainstream...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","159992","IBBQ","LNGR","BK1574","BK1515","BK1161","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705289","title":"Sihuan Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 0.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705289","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705289?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:34","pubTimestamp":1787826855,"startTime":"0","endTime":"0","summary":"Sihuan Pharma files HKEX next-day return disclosing share repurchase at HKD 0.81Sihuan Pharmaceutical repurchased 10,000,000 ordinary shares on Aug. 27, holding all as treasury shares.Buyback price ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL6cXYkS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1600","BK1191","00460","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":4,"totalSize":287,"code":"91000000","status":"200"}]}}